Cargando…
Giant morphea-form basal cell carcinoma of the umbilicus: Successful debulking with vismodegib
Basal cell carcinoma of the umbilicus is very rare. The nodular subtype is the main representative. Giant basal cell carcinomas represent around 1% of all basal cell carcinomas. The hedgehog pathway inhibitor vismodegib is indicated for advanced basal cell carcinoma and CD56-negative immunostaining...
Autores principales: | Orduz Robledo, Mariana, Lebas, Eve, Reginster, Marie-Annick, Baghaie, Mahmoud, Groves, Sabine, Nikkels, Arjen F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946607/ https://www.ncbi.nlm.nih.gov/pubmed/29760872 http://dx.doi.org/10.1177/2036361318772938 |
Ejemplares similares
-
Cutaneous Breast Cancer Metastases Successfully Treated Using an Oxygen Flow Assisted Topical Administration of Methotrexate (OFAMTX)
por: Jouret, Gaëlle, et al.
Publicado: (2020) -
A case of basal cell carcinoma arising in the umbilicus()
por: Takada, Maki, et al.
Publicado: (2023) -
Vismodegib: the Proof of Concept in Basal Cell Carcinoma
por: Berrada, Narjiss, et al.
Publicado: (2014) -
Koebner Phenomenon and Mycosis Fungoides
por: Lebas, Eve, et al.
Publicado: (2015) -
Vismodegib for giant, locally advanced, basal cell carcinoma and its complex position in clinical practice
por: Koekelkoren, Fabiënne H.J., et al.
Publicado: (2019)